Helius Medical Technologies, Inc.
HSDT
$6.21
-$0.06-0.96%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -509.99% | -52.54% | -275.89% | -0.63% | 2.18% |
| Total Depreciation and Amortization | 4,206.25% | -50.00% | -42.86% | -61.90% | -66.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 620.36% | 203.68% | 277.01% | -8.65% | -16.52% |
| Change in Net Operating Assets | 191.46% | -374.36% | 190.28% | -712.50% | 17.17% |
| Cash from Operations | 4.64% | -17.83% | -16.91% | -13.01% | -5.51% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 257.24% | 148.05% | -100.00% | -99.80% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -32.55% | -246.58% | 100.00% | -316.67% | -- |
| Cash from Financing | 36.99% | 143.13% | -100.00% | -132.75% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -300.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.76% | 101.36% | -68.32% | -45.73% | 200.29% |